MAKO Mako Surgical Corp. (MM)

Profit margins throughout the medical supplies industry are being hurt from several directions. Companies have had to lower device prices to combat the high unemployment rates, while sweeping healthcare reform that came into effect last year has also crimped profits. In addition to margin concerns, the FDA's medical device approval process continues to confuse the industry. The Bedford Report examines investing opportunities in the Medical Equipment & Supplies industry and provides equity research on MAKO Surgical Corporation (NASDAQ: MAKO) and Stryker Corporation (NYSE: SYK). Access to the full company reports can be found at:

www.bedfordreport.com/MAKO

www.bedfordreport.com/SYK

The Institute of Medicine recently recommended that the US government create a new system of approving medical devices because the current system does not guarantee the products are safe. The panel from the Institute for Medicines also said the FDA should abandon a process that allows for medical devices to be approved if the manufacturers prove they are similar to devices that are already on the market.

The Bedford Report releases market research on the Medical Equipment & Supplies Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.bedfordreport.com and get exclusive access to our numerous analyst reports and industry newsletters.

MAKO Surgical Corporation is a medical device company that markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures. The Company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient-specific osteoarthritic disease. Earlier this month the Company announced the introduction of MAKOplasty Total Hip Arthroplasty, a total hip-replacement procedure that uses the Company's RIO Robotic Arm Interactive Orthopedic System, which was approved by the FDA last year.

Stryker Corporation is a medical technology company. The Company provides orthopaedic implants, as well as medical and surgical equipment. The Company recently struck a definitive agreement to acquire privately-held stroke intervention products maker Concentric Medical Inc. for $135 million in cash.

The Bedford Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market activities. We constantly create research reports and newsletters for our members. The Bedford Report has not been compensated by any of the above-mentioned companies. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: http://www.bedfordreport.com/disclaimer.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: The Bedford Report Email Contact